- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 1.26B sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.85B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.76B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.12B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.73B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.4B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.05B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $12.28B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.91B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.51B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.04B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.28B sh |
| Stock Repurchased restated | Q1 2025 · Mar 31, 2024 | $62.7M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $9.4M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $513.8M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $7.86B |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $7.22B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.50 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.51 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $27.7M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $208.4M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $637.7M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $660.2M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $1B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.57B |